 |
194 Diseases |  |
7 Trials |
|
7 Trials |  |
234 News |  |
| «1234 |
- | Triapine (3-AP) / Vion
Trial completion, Combination therapy: A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=48, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed
- | Triapine (3-AP) / Vion
Trial completion, Combination therapy, Metastases: 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies (clinicaltrials.gov) - Feb 22, 2014
P1, N=48, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Triapine (3-AP) / Vion
Trial completion, Metastases: 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: NCIC Clinical Trials Group
Active, not recruiting --> Completed Suspended --> Completed
- Triapine (3-AP) / Vion
Trial completion: 3-AP and Cytarabine in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=0, Completed, Sponsor: Vion Pharmaceuticals
Suspended --> Completed Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Trial completion, Combination therapy, Metastases: 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Vion Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Trial completion, Combination therapy, Metastases: 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Vion Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Trial completion, Metastases: 3-AP in Treating Patients With Advanced Prostate Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Vion Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Trial completion, Combination therapy, Metastases: 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Vion Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Trial completion, Metastases: 3-AP in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Vion Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Trial completion: 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Vion Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Trial completion, Combination therapy, Metastases: 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma (clinicaltrials.gov) - Sep 26, 2013
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Enrollment open: Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer (clinicaltrials.gov) - Jul 29, 2013
P2, N=73, Recruiting, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Triapine (3-AP) / Vion
Trial completion, Metastases: Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas (clinicaltrials.gov) - Jun 2, 2013
P2, N=116, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Trial completion, Combination therapy: Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer (clinicaltrials.gov) - May 14, 2013
P2, N=78, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Triapine (3-AP) / Vion
New P2 trial: Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer (clinicaltrials.gov) - Apr 16, 2013
P2, N=73, Recruiting, Sponsor: National Cancer Institute (NCI)
- Triapine (3-AP) / Vion
Trial completion, Metastases: 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Apr 8, 2013
P1, N=24, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Recruiting --> Completed
- Triapine (3-AP) / Vion
Enrollment closed, Combination therapy, Surgery, Metastases: 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery (clinicaltrials.gov) - Mar 3, 2013
P1, N=12, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Recruiting --> Active, not recruiting
- Triapine (3-AP) / Vion
Trial termination, Metastases: 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer (clinicaltrials.gov) - Jan 14, 2013
P2, N=68, Terminated, Sponsor: National Cancer Institute (NCI)
Recruiting --> Active, not recruiting Completed --> Terminated; Administratively complete.
- Triapine (3-AP) / Vion
Enrollment change, Combination therapy, Metastases: Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies (clinicaltrials.gov) - Jan 9, 2013
P1, N=24, Completed, Sponsor: National Cancer Institute (NCI)
Completed --> Terminated; Administratively complete. N=11 --> 24
- Triapine (3-AP) / Vion
Trial completion, Combination therapy: Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer (clinicaltrials.gov) - Dec 16, 2012
P2, N=28, Completed, Sponsor: National Cancer Institute (NCI)
N=11 --> 24 Active, not recruiting --> Completed
- Triapine (3-AP) / Vion
Enrollment change, Metastases: 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Nov 19, 2012
P1, N=24, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed N=20 --> 24